German drugmaker Dermapharm plans March IPO - sources
FRANKFURT (Reuters) - German non-prescription drugmaker Dermapharm is planning to list on the Frankfurt stock exchange before the Easter holidays, in a deal that is expected to value the company at more than 1 billion euros ($1.2 billion), people familiar with the matter said.
from Reuters: Health News http://reut.rs/2D7iCXT
http://bit.ly/2zwRqiM